| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/20/2004 | US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection |
| 07/20/2004 | US6764680 Administering monoclonal antibodies |
| 07/20/2004 | CA2396927C Stabilized ascorbic acid solutions; use thereof; process for their obtention; and formulations comprising the same |
| 07/20/2004 | CA2257136C Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors |
| 07/20/2004 | CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids |
| 07/20/2004 | CA2103148C Determination of motifs of peptides on mhc molecules |
| 07/15/2004 | WO2004058969A1 Preventives/remedies for cancer |
| 07/15/2004 | WO2004058817A1 Novel proteins and use thereof |
| 07/15/2004 | WO2004058815A2 Centrosome-associated protein and applications thereof |
| 07/15/2004 | WO2004058804A1 Peptides and therapeutic uses thereof |
| 07/15/2004 | WO2004058791A2 Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 07/15/2004 | WO2004058782A1 Therapeutic quinazoline derivatives |
| 07/15/2004 | WO2004058776A1 Therapeutic agents |
| 07/15/2004 | WO2004058766A2 Tumour-inhibiting annellated azepinone derivatives |
| 07/15/2004 | WO2004058759A1 Aryl / hetaryl substituted imidazoquinolines |
| 07/15/2004 | WO2004058752A1 Quinazoline compounds |
| 07/15/2004 | WO2004058751A1 Piperidinyl-thiazole carboxamide derivatives for altering vascular tone |
| 07/15/2004 | WO2004058750A1 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors |
| 07/15/2004 | WO2004058682A1 Selective estrogen receptor modulators |
| 07/15/2004 | WO2004058302A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 07/15/2004 | WO2004058299A1 Vaccine comprising polynucleotide |
| 07/15/2004 | WO2004058294A1 Uses of interleukin-18 for treating skin disorders associated with uv radiations |
| 07/15/2004 | WO2004058279A1 Composition comprising scutellaria baicalensis and their uses thereof |
| 07/15/2004 | WO2004058275A2 Compositions of magnetic particles covered with gem-bisphosphonate derivatives |
| 07/15/2004 | WO2004058254A1 Heteroarylalkanoic acids as integrin receptor antagonists |
| 07/15/2004 | WO2004058243A1 Inhibitor for liver cancer onset and progress |
| 07/15/2004 | WO2004058191A2 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 07/15/2004 | WO2004046122A3 Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors |
| 07/15/2004 | WO2004045536A3 Method and compositions for temporarily incapaciting subjets |
| 07/15/2004 | WO2004041865A3 Stabilized single domain antibodies |
| 07/15/2004 | WO2004041863A3 Single domain antibodies directed against interferon- gamma and uses therefor |
| 07/15/2004 | WO2004032879A3 Compounds, compositions, and methods |
| 07/15/2004 | WO2004026325A3 Composition of berry extracts that prevents or inhibits angiogenesis and helicobacter pylori |
| 07/15/2004 | WO2004024879A3 RORs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 07/15/2004 | WO2004019911A3 Buccal, polar or non-polar spray or capsule containing drugs for treating endocrine disorders |
| 07/15/2004 | WO2004006846A3 Receptor-type kinase modulators and methods of use |
| 07/15/2004 | WO2004002535A8 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 07/15/2004 | WO2003100033A3 ANTI-αvβ6 ANTIBODIES |
| 07/15/2004 | WO2003093422A3 Novel tissue factor targeted antibodies as anticoagulants |
| 07/15/2004 | WO2003092613A3 Catechin multimers as therapeutic drug delivery agents |
| 07/15/2004 | WO2003092588A3 4-azasteroid derivatives as androgen receptor modulators |
| 07/15/2004 | WO2003089608A3 Drg11-responsive (dragon) gene family |
| 07/15/2004 | WO2003087108A3 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003087040A3 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003086294A3 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 07/15/2004 | WO2003075836A3 Cathepsin cysteine protease inhibitors |
| 07/15/2004 | WO2003070965A9 The eaat2 promoter and uses thereof |
| 07/15/2004 | WO2003065974A3 Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 07/15/2004 | WO2003063893B1 Fgfr agonists |
| 07/15/2004 | WO2003047506A3 Peptide agonists of prostate-specific antigen, and uses therefor |
| 07/15/2004 | WO2003045312A3 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | WO2002081636A3 Protein modification and maintenance molecules |
| 07/15/2004 | WO2002072811A3 Human prenylcysteine lyase-like protein |
| 07/15/2004 | WO2002024216A3 Method for use of igf-binding protein for selective sensitization of target cells in vivo |
| 07/15/2004 | US20040138502 Ph-dependent nmda receptor antagonists |
| 07/15/2004 | US20040138464 Compounds as enzyme inhibitors, cosmetics, antitumor agents and food supplements |
| 07/15/2004 | US20040138454 Drugs for treating pain formed by arylation |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138414 Secreted proteins |
| 07/15/2004 | US20040138411 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 07/15/2004 | US20040138299 Dispersion of bicalutamide for prostate cancer treatment |
| 07/15/2004 | US20040138286 Rho kinase inhibitors |
| 07/15/2004 | US20040138276 Metalloproteinase inhibitors |
| 07/15/2004 | US20040138270 Novel arylene-carboxylic acid (2-amino-phenyl)-amide derivatives |
| 07/15/2004 | US20040138267 Antitumor agents |
| 07/15/2004 | US20040138264 Tetrahydropyridly-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 07/15/2004 | US20040138262 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders |
| 07/15/2004 | US20040138257 Chemical derivatives and their application as antitelomerase agent |
| 07/15/2004 | US20040138256 Process for the preparation of imidazole compounds |
| 07/15/2004 | US20040138255 Modulate cell signal transduction; anticarcinogenic agents; antidiabetic agents; osteoporosis |
| 07/15/2004 | US20040138251 Anticancer agents; osteoporosis; polycystic kidney disease; antiarthritic agents; organ transplant rejection |
| 07/15/2004 | US20040138249 Pyrrolo (2.1a)dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors |
| 07/15/2004 | US20040138246 Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment |
| 07/15/2004 | US20040138245 Product comprising mikanolide, dihydromikanolide or an analogue thereof combine with another anti-cancer agent for therapeutic use in cancer treatment |
| 07/15/2004 | US20040138241 Urogenital disorders; benign protatic hyperplasia |
| 07/15/2004 | US20040138240 Antitumor agents |
| 07/15/2004 | US20040138226 Androgen sensitive diseases; prostate cancer; skin disorders; alopecia |
| 07/15/2004 | US20040138225 Analgesics; gastrointestinal disorders; central nervous system injuries |
| 07/15/2004 | US20040138218 Antitumor agents; antidiabetic agents; anticarcinogenic agents |
| 07/15/2004 | US20040138212 Disubstituted 1,7-guanines |
| 07/15/2004 | US20040138207 Antitumor agents |
| 07/15/2004 | US20040138206 Novel sulfonamide derivatives, intermidiate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 07/15/2004 | US20040138195 Activation using enzyme or ionizing radiation |
| 07/15/2004 | US20040138189 Moderation of intracellular signals; antitumor agents; drug screening; administering cucurbitacin compound |
| 07/15/2004 | US20040138188 Prevent pathology variations of signal transduction of steroid, hormone receptors |
| 07/15/2004 | US20040138186 3-Nitrogen-6, 7-dioxygen steroids and uses related thereto |
| 07/15/2004 | US20040138182 Colchicine derivatives, process for preparing them, products obtained therefrom and use thereof |
| 07/15/2004 | US20040138160 Administering tyrosine kinase inhibitor; suppression signal; blocking her gene |
| 07/15/2004 | US20040138152 adriamycin; chemotherapy; sustained release |
| 07/15/2004 | US20040138143 Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 07/15/2004 | US20040138142 Carbohydrate derivatives of paclitaxel and docetaxel, method for producing same and uses thereof |
| 07/15/2004 | US20040138140 Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy |
| 07/15/2004 | US20040138137 Alloferons - immunomodulatory peptides |
| 07/15/2004 | US20040138135 immunogens; immunotherapy; antigen presenting cells |
| 07/15/2004 | US20040138121 administering to mammals antitumor agents comprising mixtures of endothelin agonists, anticarcinogenic agents and optionally angiogenesis inhibitors |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040138112 Vaccines |
| 07/15/2004 | US20040138110 administering plasminogen activator inhibitors comprising cyclic peptides as antitumor agents; tissue-targeted therapy |
| 07/15/2004 | US20040137620 Compositions corresponding to a calcium transporter and methods of making and using same |